Zobrazeno 1 - 10
of 2 571
pro vyhledávání: '"RC254-282"'
Autor:
Xuanzhuang LU, Qiuxia QIU, Chunyu YANG, Caichen LI, Jianfu LI, Shan XIONG, Bo CHENG, Chujing ZHOU, Xiaoqin DU, Yi ZHANG, Jianxing HE, Wenhua LIANG, Nanshan ZHONG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 345-358 (2024)
Background and objective Both of lung cancer incidence and mortality rank first among all cancers in China. Previous lung cancer screening trials were mostly selective screening for high-risk groups such as smokers. Non-smoking women accounted for a
Externí odkaz:
https://doaj.org/article/2a037850d3994348985f814306dd346e
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 383-390 (2024)
Lung cancer is still the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) is the main pathological type of lung cancer, accounting for about 80%. Approximately 30% of all patients with NSCLC have resectable early and middle
Externí odkaz:
https://doaj.org/article/60cb89985369406083b5edc922a2c1cc
Autor:
Guowei CHE, Qinghua ZHOU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 325-329 (2024)
Although multidisciplinary team (MDT) diagnosis and treatment model can improve the quality of life and survival prognosis of the patients, why does it not reach the expected goal of the MDT diagnosis and treatment model? The main reason is that the
Externí odkaz:
https://doaj.org/article/79800eb666234177898483c8de724a9b
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 383-398 (2024)
Malignant pleural mesothelioma (MPM) is a rare cancer with high malignancy and aggressiveness on the pleural, caused by the following risk factors including asbestos inhalation, genetic factors, and genetic mutation. The present chemotherapy, antiang
Externí odkaz:
https://doaj.org/article/7c5665d98bf3447089c0ce01c8983923
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 337-344 (2024)
Background and objective Lung adenocarcinoma (LUAD) is a highly morbid and fatal cancer. Despite advancements in modern medical treatment, the 5-year survival rate of patients remains suboptimal. Our previous study revealed that zinc finger SWIM-type
Externí odkaz:
https://doaj.org/article/bc6b3bdaf82d4f6dbe0a575e25e106a2
Autor:
Yubin LI, Xiaoyan LI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 376-382 (2024)
Leptomeningeal metastasis (LM) is a lethal complication of malignant tumors, with an incidence rate of 3%-5% among patients with non-small cell lung cancer (NSCLC). LM poses significant challenges in diagnosis, has poor prognosis, limited treatment o
Externí odkaz:
https://doaj.org/article/84b9bf3b4b9e47bb91925ef0b0071877
Autor:
Shijun CUI, Gaoxiang WANG, Zhining HUANG, Mingsheng WU, Hanran WU, Hangcheng ZHOU, Meiqing XU, Mingran XIE
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 359-366 (2024)
Background and objective With further understanding and research into non-small cell lung cancer with tumours ≤2 cm in maximum diameter, segmental lung resection is able to achieve the same long-term prognosis as lobectomy. However, there are few s
Externí odkaz:
https://doaj.org/article/bfa13291a68e41d2885118c58d83832a
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 330-336 (2024)
Background and objective Targeted therapies are ineffective in lung squamous cancer (LUSC), and the low response rate of immunotherapy hampers its application in LUSC, so it is urgent to explore new strategies for LUSC treatment. Ferroptosis plays an
Externí odkaz:
https://doaj.org/article/eda137930f034f97825a1f1de78a16a1
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 367-375 (2024)
The incidence of cancer is closely correlated with age, as 75% of non-small cell lung cancer (NSCLC) patients are aged at least 65 years. The availability of immune checkpoint inhibitors (ICIs) has altered the available NSCLC therapeutic pattern. Lim
Externí odkaz:
https://doaj.org/article/fa11d3d083464a6198dde409a261cf6b
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 399-404 (2024)
Lung cancer is the most common malignant disease and the leading cause of cancer death in China. Non-small cell lung cancer (NSCLC) accounts for over 80% of all lung cancers, and the probability of NSCLC gene mutations is high, with a wide variety of
Externí odkaz:
https://doaj.org/article/042f379e985b4551a389e3173c941783